scholarly journals Molecular ultrasound imaging of JAM-A depicts early arterial inflammation

Aging ◽  
2018 ◽  
Vol 10 (9) ◽  
pp. 2222-2223
Author(s):  
Fabian Kiessling
2008 ◽  
Vol 43 (3) ◽  
pp. 162-169 ◽  
Author(s):  
Moritz Palmowski ◽  
Bernd Morgenstern ◽  
Peter Hauff ◽  
Michael Reinhardt ◽  
Jochen Huppert ◽  
...  

2009 ◽  
Vol 16 (5) ◽  
pp. 627-642 ◽  
Author(s):  
F. Kiessling ◽  
J. Huppert ◽  
M. Palmowski

Biomaterials ◽  
2020 ◽  
Vol 236 ◽  
pp. 119803 ◽  
Author(s):  
Guohao Wang ◽  
Lin Song ◽  
Xuandi Hou ◽  
Shashwati Kala ◽  
Kin Fung Wong ◽  
...  

2010 ◽  
Vol 41 (2) ◽  
pp. 176-184 ◽  
Author(s):  
Isabel Kiessling ◽  
Jessica Bzyl ◽  
Fabian Kiessling

Circulation ◽  
2012 ◽  
Vol 125 (25) ◽  
pp. 3117-3126 ◽  
Author(s):  
Xiaowei Wang ◽  
Christoph E. Hagemeyer ◽  
Jan David Hohmann ◽  
Ephraem Leitner ◽  
Paul C. Armstrong ◽  
...  

2015 ◽  
Vol 18 (2) ◽  
pp. 180-190 ◽  
Author(s):  
Igor Spivak ◽  
Anne Rix ◽  
Georg Schmitz ◽  
Stanley Fokong ◽  
Olga Iranzo ◽  
...  

Global Heart ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e136
Author(s):  
Xiaowei Wang ◽  
Jan David Hohmann ◽  
Ephraem Leitner ◽  
Ingo Ahrens ◽  
Christoph Hagemeyer ◽  
...  

2019 ◽  
Vol 3 (3) ◽  
pp. 62
Author(s):  
Thumar, MD Vishal ◽  
Liu, MD Ji-Bin ◽  
Eisenbrey, PhD John

Nanomaterials ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1935 ◽  
Author(s):  
Gurbet Köse ◽  
Milita Darguzyte ◽  
Fabian Kiessling

In the last decade, molecular ultrasound imaging has been rapidly progressing. It has proven promising to diagnose angiogenesis, inflammation, and thrombosis, and many intravascular targets, such as VEGFR2, integrins, and selectins, have been successfully visualized in vivo. Furthermore, pre-clinical studies demonstrated that molecular ultrasound increased sensitivity and specificity in disease detection, classification, and therapy response monitoring compared to current clinically applied ultrasound technologies. Several techniques were developed to detect target-bound microbubbles comprising sensitive particle acoustic quantification (SPAQ), destruction-replenishment analysis, and dwelling time assessment. Moreover, some groups tried to assess microbubble binding by a change in their echogenicity after target binding. These techniques can be complemented by radiation force ultrasound improving target binding by pushing microbubbles to vessel walls. Two targeted microbubble formulations are already in clinical trials for tumor detection and liver lesion characterization, and further clinical scale targeted microbubbles are prepared for clinical translation. The recent enormous progress in the field of molecular ultrasound imaging is summarized in this review article by introducing the most relevant detection technologies, concepts for targeted nano- and micro-bubbles, as well as their applications to characterize various diseases. Finally, progress in clinical translation is highlighted, and roadblocks are discussed that currently slow the clinical translation.


Sign in / Sign up

Export Citation Format

Share Document